Cargando…
P920: EVALUATION OF EARLY PROGRESSIVE DISEASE (EPD) IN NEWLY DIAGNOSED MYELOMA PATIENTS AND IDENTIFICATION OF PROGNOSTIC FACTORS IN THE ERA OF MODERN THERAPIES. THE GREEK MYELOMA STUDY GROUP EXPERIENCE.
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430951/ http://dx.doi.org/10.1097/01.HS9.0000970584.69658.38 |
| _version_ | 1785091082840702976 |
|---|---|
| author | Katodritou, Eirini Kastritis, Efstathios Dalampira, Dimitra Theodorakakou, Fotini Fotiou, Despina Delimpasi, Sosana Spanoudakis, Emmanouil Ntanasis-Stathopoulos, Ioannis Papadopoulou, Theodosia Sevastoudi, Aggeliki Triantafyllou, Theodora Daiou, Aikaterini Pouli, Anastasia Migkou, Magdalini Gavriatopoulou, Maria Verrou, Evgenia Christine Kyrtsonis, Marie Dimopoulos, Meletios A. Terpos, Evangelos |
| author_facet | Katodritou, Eirini Kastritis, Efstathios Dalampira, Dimitra Theodorakakou, Fotini Fotiou, Despina Delimpasi, Sosana Spanoudakis, Emmanouil Ntanasis-Stathopoulos, Ioannis Papadopoulou, Theodosia Sevastoudi, Aggeliki Triantafyllou, Theodora Daiou, Aikaterini Pouli, Anastasia Migkou, Magdalini Gavriatopoulou, Maria Verrou, Evgenia Christine Kyrtsonis, Marie Dimopoulos, Meletios A. Terpos, Evangelos |
| author_sort | Katodritou, Eirini |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430951 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309512023-08-17 P920: EVALUATION OF EARLY PROGRESSIVE DISEASE (EPD) IN NEWLY DIAGNOSED MYELOMA PATIENTS AND IDENTIFICATION OF PROGNOSTIC FACTORS IN THE ERA OF MODERN THERAPIES. THE GREEK MYELOMA STUDY GROUP EXPERIENCE. Katodritou, Eirini Kastritis, Efstathios Dalampira, Dimitra Theodorakakou, Fotini Fotiou, Despina Delimpasi, Sosana Spanoudakis, Emmanouil Ntanasis-Stathopoulos, Ioannis Papadopoulou, Theodosia Sevastoudi, Aggeliki Triantafyllou, Theodora Daiou, Aikaterini Pouli, Anastasia Migkou, Magdalini Gavriatopoulou, Maria Verrou, Evgenia Christine Kyrtsonis, Marie Dimopoulos, Meletios A. Terpos, Evangelos Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430951/ http://dx.doi.org/10.1097/01.HS9.0000970584.69658.38 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Katodritou, Eirini Kastritis, Efstathios Dalampira, Dimitra Theodorakakou, Fotini Fotiou, Despina Delimpasi, Sosana Spanoudakis, Emmanouil Ntanasis-Stathopoulos, Ioannis Papadopoulou, Theodosia Sevastoudi, Aggeliki Triantafyllou, Theodora Daiou, Aikaterini Pouli, Anastasia Migkou, Magdalini Gavriatopoulou, Maria Verrou, Evgenia Christine Kyrtsonis, Marie Dimopoulos, Meletios A. Terpos, Evangelos P920: EVALUATION OF EARLY PROGRESSIVE DISEASE (EPD) IN NEWLY DIAGNOSED MYELOMA PATIENTS AND IDENTIFICATION OF PROGNOSTIC FACTORS IN THE ERA OF MODERN THERAPIES. THE GREEK MYELOMA STUDY GROUP EXPERIENCE. |
| title | P920: EVALUATION OF EARLY PROGRESSIVE DISEASE (EPD) IN NEWLY DIAGNOSED MYELOMA PATIENTS AND IDENTIFICATION OF PROGNOSTIC FACTORS IN THE ERA OF MODERN THERAPIES. THE GREEK MYELOMA STUDY GROUP EXPERIENCE. |
| title_full | P920: EVALUATION OF EARLY PROGRESSIVE DISEASE (EPD) IN NEWLY DIAGNOSED MYELOMA PATIENTS AND IDENTIFICATION OF PROGNOSTIC FACTORS IN THE ERA OF MODERN THERAPIES. THE GREEK MYELOMA STUDY GROUP EXPERIENCE. |
| title_fullStr | P920: EVALUATION OF EARLY PROGRESSIVE DISEASE (EPD) IN NEWLY DIAGNOSED MYELOMA PATIENTS AND IDENTIFICATION OF PROGNOSTIC FACTORS IN THE ERA OF MODERN THERAPIES. THE GREEK MYELOMA STUDY GROUP EXPERIENCE. |
| title_full_unstemmed | P920: EVALUATION OF EARLY PROGRESSIVE DISEASE (EPD) IN NEWLY DIAGNOSED MYELOMA PATIENTS AND IDENTIFICATION OF PROGNOSTIC FACTORS IN THE ERA OF MODERN THERAPIES. THE GREEK MYELOMA STUDY GROUP EXPERIENCE. |
| title_short | P920: EVALUATION OF EARLY PROGRESSIVE DISEASE (EPD) IN NEWLY DIAGNOSED MYELOMA PATIENTS AND IDENTIFICATION OF PROGNOSTIC FACTORS IN THE ERA OF MODERN THERAPIES. THE GREEK MYELOMA STUDY GROUP EXPERIENCE. |
| title_sort | p920: evaluation of early progressive disease (epd) in newly diagnosed myeloma patients and identification of prognostic factors in the era of modern therapies. the greek myeloma study group experience. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430951/ http://dx.doi.org/10.1097/01.HS9.0000970584.69658.38 |
| work_keys_str_mv | AT katodritoueirini p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT kastritisefstathios p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT dalampiradimitra p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT theodorakakoufotini p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT fotioudespina p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT delimpasisosana p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT spanoudakisemmanouil p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT ntanasisstathopoulosioannis p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT papadopouloutheodosia p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT sevastoudiaggeliki p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT triantafylloutheodora p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT daiouaikaterini p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT poulianastasia p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT migkoumagdalini p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT gavriatopouloumaria p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT verrouevgenia p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT christinekyrtsonismarie p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT dimopoulosmeletiosa p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience AT terposevangelos p920evaluationofearlyprogressivediseaseepdinnewlydiagnosedmyelomapatientsandidentificationofprognosticfactorsintheeraofmoderntherapiesthegreekmyelomastudygroupexperience |